HomeANEB • NASDAQ
add
Anebulo Pharmaceuticals Inc
Previous close
$2.90
Day range
$2.94 - $3.07
Year range
$1.62 - $4.05
Market cap
76.76M USD
Avg Volume
5.19K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 2.76M | -27.61% |
Net income | -2.72M | 28.99% |
Net profit margin | — | — |
Earnings per share | -0.11 | 26.67% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 6.64M | -59.37% |
Total assets | 7.50M | -55.59% |
Total liabilities | 1.01M | -26.15% |
Total equity | 6.49M | — |
Shares outstanding | 25.93M | — |
Price to book | 11.60 | — |
Return on assets | -83.40% | — |
Return on capital | -93.14% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -2.72M | 28.99% |
Cash from operations | -1.81M | 30.49% |
Cash from investing | — | — |
Cash from financing | -62.35K | 74.95% |
Net change in cash | -1.88M | 34.37% |
Free cash flow | -841.52K | 40.51% |
About
Founded
2020
Headquarters
Website
Employees
2